# Impact of Colostrum Oropharyngeal Immunotherapy on Postnatal Growth in Preterm Infants

> **NCT07082881** · NA · NOT_YET_RECRUITING · sponsor: **Suqian First Hospital** · enrollment: 220 (estimated)

## Conditions studied

- Growth Failure
- Preterm Birth
- Microbiota

## Interventions

- **OTHER:** Colostrum
- **OTHER:** Normal Saline

## Key facts

- **NCT ID:** NCT07082881
- **Lead sponsor:** Suqian First Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2028-08-31
- **Final completion:** 2028-09-30
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2025-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07082881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07082881, "Impact of Colostrum Oropharyngeal Immunotherapy on Postnatal Growth in Preterm Infants". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07082881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*